Analysis of Smoking Cessation Product Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Advancing at a compound annual growth rate (CAGR) of 9.2% on the back of more people looking to quit smoking than ever before, the global smoking cessation product market is estimated at US$ 28.9 billion in 2024 and has been analyzed to reach US$ 69.8 billion by the end of 2034, as revealed in a recently published research analysis by Fact.MR.
Increasing count of individuals trying to quit smoking around the world is set to act as one of the prominent factors contributing to the smoking cessation product market growth. Various governments around the world are emphasizing stringent regulations for controlling the addiction to cigarettes and nicotine owing to their toxic effects on respiratory and cardiac systems. In addition, the imposition of higher taxes on tobacco products is also anticipated to contribute to the rising demand for alternative safe options, which are further helping in the expansion of the smoking cessation product market size.
Several government policies have been implemented regarding smoking, such as the prohibition on smoking in public areas. Further, rising awareness about the adverse effects of smoking among people is set to positively impact market growth.
In recent years, the hectic lifestyle of more people is contributing to stress and unhealthy habits, such as smoking, etc., which is resulting in the generation of health issues. COPD (chronic obstructive pulmonary disease) is one of the life-threatening diseases, caused due to excessive smoking. Therefore, increased emphasis has been given to quitting such habits, which is forecasted to contribute to the rising sales of smoking cessation products in the coming 10 years. The trend of quitting smoking is more common among lactating and pregnant women due to its adverse impacts on the mother as well as the child. These factors are set to positively impact market growth.
| Report Attributes | Details |
|---|---|
| Smoking Cessation Product Market Size (2024E) | US$ 28.9 Billion |
| Forecasted Market Value (2034F) | US$ 69.8 Billion |
| Global Market Growth Rate (2024 to 2034) | 9.2% CAGR |
| Market Share of Chewing Gum (2034F) | 23.8% |
| South Korea Market Growth Rate (2024 to 2034) | 10% CAGR |
| North America Market Share (2034F) | 24.3% |
| Key Companies Profiled | Johnson & Johnson Inc.; The Harvard Drug Group; GlaxoSmithKline plc; Smoke Away; Pfizer Inc.; British American Tobacco PLC; Perrigo Company plc; Novartis; Cipla Ltd.; Nicotek LLC; ITC Limited; Fontem Ventures; Alkalon A/S; Reynolds American Inc.; Fertin Pharma; Imperial Tobacco Ltd.; VMR Products LLC |
“Rising Cases of COPD Diseases Increasing Demand for Smoking Cessation Solutions”
Smoking tobacco is one of the prominent causes of COPD (chronic obstructive pulmonary disease). There are various people around the world, who are suffering from COPD. This disease is anticipated to be one of the most prominent causes of death by the end of 2034. This life-threatening disease does not have a cure. Therefore, more people are becoming aware of the adverse effects of smoking, which is subsequently generating demand for smoking cessation products as one of the ways to quit smoking.
“Escalating Count of Tobacco-related Deaths”
As per the WHO (World Health Organization), consumption of tobacco is resulting in increasing deaths around the world. Rising awareness related to the hazards of the consumption of tobacco is expected to stimulate individuals to quit smoking. This quit-smoking trend is more prevalent among lactating and pregnant women, as adverse impacts are caused on mothers and children.
“Potential Side Effects Associated with Smoking Cessation Products”
Smoking cessation products are marketed to help individuals quit smoking. However, several side effects of these products are leading to discomfort. Certain products, including nasal sprays, patches, etc., are anticipated to cause irritation to the nose, skin, throat, or eyes. Even some behavioral changes are also noticed among consumers. There are a few smoking cessation products, which lead to diarrhea and insomnia as side-effects with their consumption. Therefore, growing awareness among consumers about the health risks associated with these products is expected to adversely influence smoking cessation product market trends.
“Investments in Production of Personalized Smoking Cessation Products”
New entrants trying to enter this marketplace are investing at an increased rate for the production of customized smoking cessation products. These newly developed products are estimated to help COPD patients, therefore leading to their growing sales.
North America is forecast to account for 24.3% share of global market revenue by 2034. The presence of some prominent players, well-developed healthcare infrastructure, and increasing government initiatives for public awareness about the adverse impacts of smoking are contributing to the rising demand for smoking cessation products.
“Higher Awareness about Adverse Impacts of Smoking on Health”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 3.1 Billion |
| Growth Rate (2024 to 2034) | 9.6% CAGR |
| Projected Value (2034F) | US$ 7.7 Billion |
The United States is set to hold a 45.6% share of the North American market by the end of 2034. Tobacco smoking is anticipated to reach new heights in the United States owing to the alarming adoption of several types of tobacco products among the adult population and youth. However, certain individuals are inclined to quit smoking with rising health awareness and increasing health disorders, which is projected to positively impact demand for smoking cessation products in the United States.
“Presence of Larger Base of Smokers Leading to Several Health Issues”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 3.2 Billion |
| Growth Rate (2024 to 2034) | 9.2% CAGR |
| Projected Value (2034F) | US$ 7.7 Billion |
China is anticipated to account for 47.5% share of the market in East Asia by the end of 2034. Increasing awareness about the availability and effectiveness of smoking cessation products among a larger consumer base is anticipated to widen opportunities for players. With a significant presence of smokers in China an increase in the demand for smoking cessation products has been encountered with rising health issues and awareness about the adverse health impacts of smoking.
The study published by Fact.MR, a market research and competitive intelligence provider, states that increasing demand for chewing gum is attributed to its help in reducing harm, which is otherwise caused by several high-risk products, including combustible cigarettes. In addition, it also helps in minimizing cravings for nicotine consumption.
“Rising Use of Chewing Gum to Control Nicotine Cravings”
| Attribute | Chewing Gum |
|---|---|
| Segment Value (2024E) | US$ 7.1 Billion |
| Growth Rate (2024 to 2034) | 8.8% CAGR |
| Projected Value (2034F) | US$ 16.6 Billion |
Chewing gum is projected to contribute 23.8% share of the global market by 2034, as mentioned in the research report published by Fact.MR. The rising demand for chewing gum as a smoking cessation product is owing to its ability to control sudden cravings for nicotine and withdrawal symptoms. In addition, it is anticipated to be used in combination with other smoking cessation products, which will further widen opportunities for players.
“Increased Effectiveness of NRT Therapy in Quitting Smoking”
| Attribute | Nicotine Replacement Therapy (NRT) |
|---|---|
| Segment Value (2024E) | US$ 10.2 Billion |
| Growth Rate (2024 to 2034) | 9.5% CAGR |
| Projected Value (2034F) | US$ 25.4 Billion |
Nicotine replacement therapy is forecast to account for a 36.4% share of global market revenue by 2034 because of its effectiveness in quitting smoking. In this therapy, a low dose of nicotine is used along with the products without any toxins. Further, this therapy is anticipated to help in cutting down on cravings for nicotine. Different forms of products, such as transdermal patches, inhalers, gum, etc., are used in NRT therapy to increase the chances of quitting smoking.
Leading manufacturers of smoking cessation products are involved in the production of innovative solutions. In addition, players are also investing to maintain product quality, new product development, management of supply chain systems, etc., to get a competitive edge in the global market.
Key players in the smoking cessation product industry are Johnson & Johnson Inc., The Harvard Drug Group, GlaxoSmithKline plc, Smoke Away, Pfizer Inc., British American Tobacco PLC, Perrigo Company plc, Novartis, Cipla Ltd., Nicotek LLC, ITC Limited, Fontem Ventures, Alkalon A/S, Reynolds American Inc., Fertin Pharma, Imperial Tobacco Ltd., and VMR Products LLC.
How big is the size of the smoking cessation product market in 2024?
The global smoking cessation product market is estimated at US$ 28.9 billion in 2024.
What is the sales outlook for smoking cessation products by 2034?
Worldwide demand for smoking cessation products is forecasted to reach a market valuation of US$ 69.8 billion by 2034.
What is the projected CAGR for the market from 2024 to 2034?
The market for smoking cessation products is projected to expand at 9.2% CAGR from 2024 to 2034.
How much share of the global market is forecasted to be accounted for by North America?
North America is anticipated to contribute 24.3% share of the global market by the end of 2034.
What is the demand projection for smoking cessation products in Japan?
Sales of smoking cessation products in Japan are set to rise at a CAGR of 9.7% from 2024 to 2034.
What is the contribution of chewing gum to global market revenue?
Chewing gum is forecasted to hold 23.8% share of global market revenue by the end of 2034.
Smoking Cessation Product Market